Aarhus University logo
This month DANDRITE celebrates 10 years of existence. With a new generation of highly talented group leaders already recruited, the research center is ready to embark on a new decade.
NCMM group leader Anthony Mathelier will be the new Associate Director of the Centre, combined with a part-time Professor II position at the Centre for Bioinformatics.
A clinical trial performed in Finland has shown that a drug sensitivity test performed on patient's own cells in laboratory conditions predicts patient's response to a new effective leukemia drug, venetoclax. The method helps to identify leukemia patients who would benefit from this treatment.
Nikoline Rasmussen joined NCMM as communications officer in January 2023. She completed her PhD studies at the field of molecular Biology to then turn towards science communications.
Women scientists of the Nordic EMBL Partnership on the forefront of molecular medicine research
Dr Laura Carroll, assistant university lecturer at the Department of Clinical Microbiology (Umeå University), DDLS Fellow, MIMS Investigator, UCMR PI and IceLab Affiliate. She wants to develop methods that biologists and clinicians can use to draw conclusions from their omics data—especially genomics and metagenomics data—to improve human, animal and environmental health.
In January 2023, DANDRITE welcomed a new, fourth member of senior management, Professor Jelena Radulovic.
New results from the FinnGen study demonstrate the undeniable benefits of Finnish health research environment for genomic research. Among the wealth of genetic discoveries are novel genetic risk factors for many debilitating diseases. These findings have potential to facilitate the development of new therapies.
The Lundbeck Foundation fuels young neuroscientist's biotech vision with a DKK 5 million grant from its new Frontier Grant programme. Lasse Reimer of DANDRITE at Aarhus University will spend the next 18 months bringing the promising project to maturity and taking it out of the lab in search of investors.
The High Throughput Biomedicine Unit at FIMM: Meet Laura Turunen and Jani Saarela, and learn how the unit is ready to help you answer your research questions
Page 1 of 21.
Members of the Nordic EMBL Partnership for Molecular Medicine will be hosted in Helsinki in 2023 for the Annual Meeting. Program and more information…
A new transporter, vital for cell wall integrity of bacteria, has been identified by researchers at Umeå University in the plant pathogen, Agrobacterium tumafaciens. This discovery shows a new potential target for antibiotics.
Researchers at Umeå University can now show how the dreaded poliovirus behaves when it takes over an infected cell and tricks the cell into producing new virus particles.
Researchers have, for the first time, systematically estimated the impact of a range of different disease-associated genetic risk factors on the loss of healthy life years. The new study, published in Nature Medicine, shows the impact of different genetic risk factors on disease burden can help prioritise and design interventions using genetic data.
Dr. Andrea Puhar and her team at The Laboratory for Molecular Infection Medicine Sweden (MIMS) at Umeå University, discovered that gut cells sense harmful bacteria through the mechanical force exerted on their cell surface during bacterial invasion.
Abnormal epigenetic changes are observed in the development of multiple types of cancer. Researchers at NCMM, Norwegian node of the Nordic EMBL Partnership, explored the molecular mechanisms driving these processes.
Researchers from FIMM review how human genetics can inform the biology and epidemiology of COVID-19 by pinpointing causal mechanisms that explain why some individuals become more severely affected by the disease upon infection by SARS-CoV-2 virus.
Researchers from Umeå University, Sweden, analyzed all COVID-19 cases in Sweden from the start of the pandemic until May last year and determined that COVID-19 is a risk factor for deep vein thrombosis, pulmonary embolism, and bleeding.
This study from researchers at MIMS and their collaborators, published in PloS Pathogens opens up new ways of selectively eradicating intracellular infection, proposing the inhibition of alaninol formation as a novel way of acting on infections caused by Salmonella.
Researchers from the Institute for Molecular Medicine Finland (FIMM) and collaborators at Helsinki Institute for Information Technology (HIIT) present a new computational platform, ScType, for cell profiling based single-cell RNA-sequencing data. They also demonstrate how it distinguishes between healthy and malignant cells, making it a versatile tool also for cancer applications. Open access through a web-based interface or as an open source R-package.
The female sex hormone oestrogen may have some protective effect against becoming seriously ill and dying in COVID-19, according to a registry study conducted at Umeå University. If so, this could explain why men are more likely than women to die during the pandemic.
Page 1 of 4.
